Category: covid-19 vaccines

COVID-19 Vaccine Prices: Comparing the U.S. and EU


This post is by Carmen Ang from Visual Capitalist


Vaccines Prices

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

The Briefing

  • The U.S. paid 32.1% more per dose for the Pfizer vaccine, compared to the EU
  • Between the two areas, the Sanofi vaccine has one of the smallest prices gaps of only 12.9%

Comparing COVID Vaccine Prices between the U.S. and EU

Over two billion COVID-19 vaccine doses have been administered around the world.

But the price governments have paid for the vaccine varies, depending on the region or country. Here’s a look at five major vaccine manufacturers, and their price per dose in the U.S. compared to the EU.

COVID-19 Vaccine Prices: Cost Per Dose

Generally speaking, the EU has paid significantly less than America for a range of COVID-19 vaccines. Pfizer has the biggest price gap, with the U.S. paying 32.1% more per dose.

ManufacturerU.S. Price (per dose)EU Price (per dose)% Difference U.S. is paying
Pfizer/BioNTech$19.50$14.7632.1%
Moderna$15.00$18.00-20.0%
Sanofi$10.50$9.3012.9%
Johnson & Johnson$10.00$8.5017.6%
AstraZeneca$4.00$3.5014.3%

There are a few factors that might explain the price difference. One is (Read more...)

Visualized: Key Events in the COVID-19 Timeline


This post is by Iman Ghosh from Visual Capitalist


COVID-19 timeline: key events of the pandemic

All dates in the graphic are based on when events occurred rather than when they were widely reported.

Visualized: Key Events in the COVID-19 Timeline

It’s been a long and eventful year since COVID-19 was officially declared a global pandemic by the World Health Organization (WHO) on March 11, 2020.

The tangible and intangible costs of COVID-19 have been severe. In this visual COVID-19 timeline, we delve into some significant milestones that have occurred around the world.

December 2019-February 2020

Pre-Pandemic COVID-19 Timeline

The origin story actually begins at the turn of the new year, as events began bubbling under the surface in Wuhan, China. The first coronavirus cluster was reported on December 31, 2019, with initial exposures linked to the Huanan Seafood Market.

In the new year, the first coronavirus cases began filtering outside of China, to Thailand and the U.S.—causing the WHO to declare a public health emergency of international concern. As the death toll ticked up to over 200, it was clear that this was no ordinary virus.

covid-19 prepandemic events timeline

All dates in the graphic are based on when events occurred rather than when they were widely reported.

In February 2020, the novel coronavirus was finally named COVID-19. In addition, the Diamond Princess cruise ship was linked to 624 confirmed cases in late February—the highest case cluster outside of China at the time. The ship captured international headlines when it was refused port in a number of countries, casting COVID-19 into the spotlight.

This month also marked a (Read more...)

COVID-19 Vaccine Doses: Who’s Got At Least One?


This post is by Avery Koop from Visual Capitalist



Note: Use the “Add Country” (top left) function to add countries to the list. This visualization updates regularly.

COVID-19 Vaccine Doses: Who’s Got At Least One?

With COVID-19 vaccine rollouts well underway in some countries, a return to ‘normal life’ could come sooner than later.

That said, many jurisdictions have experienced serious delays and supply shortages that have made it difficult to distribute COVID-19 vaccine doses to their populations. As of mid-February, 130 countries had not been able to begin vaccinating at all.

This interactive chart from Our World in Data tracks the share of people in each country that have received COVID-19 vaccine doses so far.

The Global Vaccine Rollout

As of publication date, roughly 100 countries have begun vaccine distribution, with about seven different vaccines available for public use at this stage.

The sheer logistical challenge of doling out vaccines is immense. Experts estimate that 70-80% of the world’s population will need to be vaccinated to reach herd immunity. Additionally, some of the vaccines require two doses which adds extra time and complexity to the process.

Here’s how the various vaccines compare in terms of required doses and levels of effectiveness.

VaccineNumber of Shots RequiredEffectiveness
Pfizer/BioNTech295%
Moderna295%
Oxford/AstraZeneca270%
Johnson & Johnson166%
Novavax (*Novavax has not yet been approved for public use)289%
Sinovac Biotech250%
Gamaleya (Sputnik)292%
CanSino Biologics166%
Sinopharm279%

Source: Bloomberg Vaccine Tracker

One key barrier to successfully administering (Read more...)

Visualizing Global Attitudes Towards the COVID-19 Vaccines


This post is by Katie Jones from Visual Capitalist


View the full-resolution version of this infographic
Visualizing Global Attitudes Towards COVID-19 Vaccines

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

Visualizing Global Attitudes Towards COVID-19 Vaccines

View the high-resolution of the infographic by clicking here.

To vaccinate, or not to vaccinate? That is the question.

In order to achieve herd immunity against COVID-19, some experts believe that between 70% to 80% of a population must be vaccinated.

But attitudes towards these vaccines are undoubtedly mixed. In fact, it’s estimated that one-third of people globally have some major concerns.

Using survey data from eight different countries, Global Web Index created five archetypes to help illustrate how typical attitudes towards vaccines differ depending on a range of factors, such as age, income, lifestyle, and values.

SegmentBreakdownAge SkewGender SkewIncomeVaccine Concerns
Vaccine Supporter66%18-34NoneHigh incomePotential side-effects, availability, and logistics of vaccine distribution.
Vaccines Hesitant12%38-56FemaleLow/Middle incomePotential side-effects specifically due to no long-term testing, cost of vaccine, and more transparency around science required.
Vaccine Obligated11%16-24MaleLow incomePotential side-effects, not sure COVID-19 vaccine is necessary to combat (Read more...)